Ketamine by intravenous, sublingual and oral route of administration for treatment of pain:pharmacokinetics

Phase 4

Completed

• Conditions: Acute pain; Alternative and Complementary Medicine - Pain management

• Registration Number: ACTRN12605000220662
• Lead Sponsor: Professor Stephan Schug

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-26
• Study Completion: 2005-10-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

Previously on ketamine.

Exclusion Criteria

Coronary artery disease,hypertension,tachyarrythmias,impaired renal function,pregnancy,lactation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Drug pharmacokinetics for 8 hours after oral and sublingual routes of administration compared with intravenous[]